These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6359846)

  • 21. Long-term oral bronchodilator therapy of asthma with pirbuterol.
    Burki NK; Diamond L
    Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enalapril for severe congestive heart failure. A double-blind study.
    Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J
    Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
    Smiseth OA
    Eur J Pharmacol; 1983 Mar; 87(4):379-86. PubMed ID: 6133759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
    Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo.
    Ferraro S; Codella C; Palumbo F; Desiderio A; Trimigliozzi P; Maddalena G; Chiariello M
    Clin Cardiol; 1996 Sep; 19(9):699-703. PubMed ID: 8874988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies on pirbuterol, salbutamol and a placebo administered as an aerosol in asthmatic patients].
    Verstraeten JM
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):200-3. PubMed ID: 552144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.
    Poppius H; Lehti H; Stenius-Aarniala B
    Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart failure in outpatients: a randomized trial of digoxin versus placebo.
    Lee DC; Johnson RA; Bingham JB; Leahy M; Dinsmore RE; Goroll AH; Newell JB; Strauss HW; Haber E
    N Engl J Med; 1982 Mar; 306(12):699-705. PubMed ID: 7038483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
    Canepa-Anson R; Dawson JR; Kuan P; Warnes CA; Poole-Wilson PA; Reuben SR; Sutton GC
    Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis.
    Winter RJ; Langford JA; Rudd RM
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):824-5. PubMed ID: 6142748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
    Ashutosh K; Dev G; Steele D
    Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
    Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG
    Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.